Literature DB >> 10085010

An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.

B H Jost1, J G Songer, S J Billington.   

Abstract

Pyolysin (PLO), the hemolytic exotoxin expressed by Arcanobacterium (Actinomyces) pyogenes, is a member of the thiol-activated cytolysin family of bacterial toxins. Insertional inactivation of the plo gene results in loss of expression of PLO with a concomitant loss in hemolytic activity. The plo mutant, PLO-1, has an approximately 1. 8-log10 reduction in the 50% infectious dose compared to that for wild-type A. pyogenes in a mouse intraperitoneal infection model. Studies involving cochallenge of wild-type and PLO-1 bacteria resulted in recovery of similar numbers of both strains, suggesting that PLO production is required for survival in vivo. Recombinant, His-tagged PLO (His-PLO) is cytotoxic for mouse peritoneal macrophages and J774 cells in a dose-dependent manner. Protection against challenge with A. pyogenes could be afforded by vaccination with formalin-inactivated His-PLO, suggesting that PLO is a host-protective antigen, as well as a virulence determinant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085010      PMCID: PMC96520          DOI: 10.1128/IAI.67.4.1723-1728.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Pathogenesis of sepsis syndrome: possible relevance of pore-forming bacterial toxins.

Authors:  S Bhakdi; I Walev; D Jonas; M Palmer; U Weller; N Suttorp; F Grimminger; W Seeger
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

2.  Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis.

Authors:  A A Jacobs; A J van den Berg; P L Loeffen
Journal:  Vet Rec       Date:  1996-09-07       Impact factor: 2.695

Review 3.  Determination of median lethal and infectious doses in animal model systems.

Authors:  S Welkos; A O'Brien
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

Review 5.  Human infections with Actinomyces pyogenes (Corynebacterium pyogenes).

Authors:  B Gahrn-Hansen; W Frederiksen
Journal:  Diagn Microbiol Infect Dis       Date:  1992 May-Jun       Impact factor: 2.803

Review 6.  [The possible pathogenic factors of Actinomyces pyogenes. A review].

Authors:  C Lämmler
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1990-04-01       Impact factor: 0.328

7.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.

Authors:  J E Alexander; R A Lock; C C Peeters; J T Poolman; P W Andrew; T J Mitchell; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Corynebacterium pyogenes. Its pathogenic mechanism in epidemic leg ulcers in Thailand.

Authors:  R Kotrajaras; H Tagami
Journal:  Int J Dermatol       Date:  1987 Jan-Feb       Impact factor: 2.736

9.  Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin.

Authors:  M Nandoskar; A Ferrante; E J Bates; N Hurst; J C Paton
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

10.  Construction and characterization of a Mycobacterium-Escherichia coli shuttle vector.

Authors:  A J Radford; A L Hodgson
Journal:  Plasmid       Date:  1991-03       Impact factor: 3.466

View more
  15 in total

1.  An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.

Authors:  B H Jost; J G Songer; S J Billington
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  Cloning, expression, and characterization of a neuraminidase gene from Arcanobacterium pyogenes.

Authors:  B H Jost; J G Songer; S J Billington
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Immunization with genetic toxoids of the Arcanobacterium pyogenes cholesterol-dependent cytolysin, pyolysin, protects mice against infection.

Authors:  B Helen Jost; Hien T Trinh; J Glenn Songer; Stephen J Billington
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Widespread distribution of a tet W determinant among tetracycline-resistant isolates of the animal pathogen Arcanobacterium pyogenes.

Authors:  Stephen J Billington; J Glenn Songer; B Helen Jost
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  Isolation of Arcanobacterium pyogenes from the porcine gastric mucosa.

Authors:  B H Jost; K W Post; J G Songer; S J Billington
Journal:  Vet Res Commun       Date:  2002-08       Impact factor: 2.459

7.  The Arcanobacterium pyogenes collagen-binding protein, CbpA, promotes adhesion to host cells.

Authors:  Paula A Esmay; Stephen J Billington; Malen A Link; J Glenn Songer; B Helen Jost
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Trueperella pyogenes pyolysin inhibits lipopolysaccharide-induced inflammatory response in endometrium stromal cells via autophagy- and ATF6-dependent mechanism.

Authors:  Maozhen Qi; Jianguo Liu; Qingran Jiang; Hongyu Niu; Xinyu Wang; Dong Zhou; Pengfei Lin; Huatao Chen; Aihua Wang; Yaping Jin
Journal:  Braz J Microbiol       Date:  2021-01-16       Impact factor: 2.476

9.  The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages.

Authors:  Elise M Mosser; Richard F Rest
Journal:  BMC Microbiol       Date:  2006-06-21       Impact factor: 3.605

Review 10.  The MACPF/CDC family of pore-forming toxins.

Authors:  Carlos J Rosado; Stephanie Kondos; Tara E Bull; Michael J Kuiper; Ruby H P Law; Ashley M Buckle; Ilia Voskoboinik; Phillip I Bird; Joseph A Trapani; James C Whisstock; Michelle A Dunstone
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.